| Literature DB >> 29142168 |
Kenichiro Kasahara1, Yachiyo Fukunaga1, Saori Igura1, Rie Andoh2, Tsubasa Saito2, Isamu Suzuki2, Hiroyuki Kanemitsu1, Daisuke Suzuki1, Ken Goto2, Daichi Nakamura1, Masahiro Mochizuki2, Masahiko Yasuda3, Ryo Inoue3, Kazutoshi Tamura2, Mariko Nagatani2.
Abstract
To obtain background data of NOD/Shi-scid IL-2Rγnull (NOG) mice, severely immunedeficient mice, a total of 120 animals were examined at 7, 26 and 52 weeks-old (20 mice/sex/group). The survival rate at 52 weeks-old was 95% (19/20) in both sexes. Clinically, circling behavior in one direction along the cage wall was observed in males after 8 weeks and females after 47 weeks-old, and hunchback position was found in males after 32 weeks-old. Hematologically, lymphocyte count markedly decreased at all ages, while white blood cell count increased in several mice at 52 weeks-old. Blood chemistry results revealed high values of aspartate aminotransferase, lactate dehydrogenase and creatine phosphokinase in some females at 26 weeks-old, without any related histological change. Histologically, lymphoid hypoplasia characterized by severe lymphocyte depletion with poorly developed tissue architectures was observed. In addition, spongiotic change in the nerve tissue was observed in both sexes at 7 and 26 weeks-old, and intracytoplasmic materials known as tubular aggregates in the skeletal muscles were found in males terminated at 26 and 52 weeks-old and in females at 52 weeks-old. Malignant lymphoma was found in one female euthanized at 20 weeks-old. Further, small intestinal adenoma, hepatocellular adenoma, leukemia, cerebral lipomatous hamartoma, Harderian gland adenoma and uterine polyp were also observed, and their incidences were low except for that of uterine polyp. This study provided detailed background data on NOG mice up to 52 weeks-old and provided information on appropriate use of NOG mice in the various research fields.Entities:
Keywords: Background data; Immuno-deficient; Lymphoid hypoplasia; NOG mice; Spongiotic changes; Tubular aggregate
Mesh:
Substances:
Year: 2017 PMID: 29142168 DOI: 10.2131/jts.42.689
Source DB: PubMed Journal: J Toxicol Sci ISSN: 0388-1350 Impact factor: 2.196